Literature DB >> 9831755

Molecular dissection of Norrie disease.

W Berger1.   

Abstract

Norrie disease (ND) is a severe form of congenital blindness accompanied by mental retardation and/or deafness in at least one third of the patients. This article summarizes advances in the molecular genetic analysis of this disease during the last 13 years, including mapping and cloning of the human gene and the generation and characterization of a mouse model. Genetic linkage studies and physical mapping strategies have assigned the ND locus to the proximal short arm of the human X chromosome. The identification of chromosomal rearrangements in several patients, such as microdeletions, enabled the isolation of the ND gene by a positional cloning approach. Numerous point mutations in this gene have been identified in three distinct clinical entities: (1) ND, (2) familial and sporadic exudative vitreoretinopathy, and (3) retinopathy of prematurity. The gene encodes a relatively small protein, consisting of 133 amino acids. The function of the gene product is yet unknown, although homologies with known proteins and molecular modelling data suggest a role in the regulation of cell interaction or differentiation processes. A mouse model has been generated to shed more light on early pathogenic events involved in ND and allelic disorders. The mouse homologous protein is highly identical (94%) to the human polypeptide. The gene is expressed in the neuronal layers of the mouse retina, the cerebellum and olfactory epithelium. Mutant mice show snowflake-like opacities within the vitreous, dysgenesis of the ganglion cell layer and occasionally degeneration of photoreceptor cells. The mouse phenotype does not include phthisis bulbi and, overall, resembles a mild form of ND. Electrophysiological studies revealed a severely altered electroretinogram b-wave. These results suggest a primary defect in the inner neuronal layers of the retina. Defects in the vitreous and photoreceptor cell layer are most likely secondary effects. Further histological, functional and molecular studies of the mouse model are needed to provide additional information on disease associated pathways.

Entities:  

Mesh:

Year:  1998        PMID: 9831755     DOI: 10.1159/000046473

Source DB:  PubMed          Journal:  Acta Anat (Basel)        ISSN: 0001-5180


  12 in total

Review 1.  Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies.

Authors:  Gerd Holmström; Peter van Wijngaarden; Douglas J Coster; Keryn A Williams
Journal:  Br J Ophthalmol       Date:  2007-12       Impact factor: 4.638

Review 2.  Secreted and transmembrane wnt inhibitors and activators.

Authors:  Cristina-Maria Cruciat; Christof Niehrs
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-03-01       Impact factor: 10.005

3.  Further evidence of genetic heterogeneity in familial exudative vitreoretinopathy; exclusion of EVR1, EVR3, and EVR4 in a large autosomal dominant pedigree.

Authors:  C Toomes; L M Downey; H M Bottomley; H A Mintz-Hittner; C F Inglehearn
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

Review 4.  Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis).

Authors:  Mary Elizabeth Hartnett
Journal:  Trans Am Ophthalmol Soc       Date:  2010-12

5.  Differentiation of the brain vasculature: the answer came blowing by the Wnt.

Authors:  Stefan Liebner; Karl H Plate
Journal:  J Angiogenes Res       Date:  2010-01-14

6.  Endothelial SRF/MRTF ablation causes vascular disease phenotypes in murine retinae.

Authors:  Christine Weinl; Heidemarie Riehle; Dongjeong Park; Christine Stritt; Susanne Beck; Gesine Huber; Hartwig Wolburg; Eric N Olson; Mathias W Seeliger; Ralf H Adams; Alfred Nordheim
Journal:  J Clin Invest       Date:  2013-04-08       Impact factor: 14.808

7.  Biophysical and functional characterization of Norrin signaling through Frizzled4.

Authors:  Injin Bang; Hee Ryung Kim; Andrew H Beaven; Jinuk Kim; Seung-Bum Ko; Gyu Rie Lee; Wei Kan; Hasup Lee; Wonpil Im; Chaok Seok; Ka Young Chung; Hee-Jung Choi
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-13       Impact factor: 11.205

8.  Retinal expression of Wnt-pathway mediated genes in low-density lipoprotein receptor-related protein 5 (Lrp5) knockout mice.

Authors:  Jing Chen; Andreas Stahl; Nathan M Krah; Molly R Seaward; Jean-Sebastian Joyal; Aimee M Juan; Colman J Hatton; Christopher M Aderman; Roberta J Dennison; Keirnan L Willett; Przemyslaw Sapieha; Lois E H Smith
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

9.  Microphthalmia, persistent hyperplastic hyaloid vasculature and lens anomalies following overexpression of VEGF-A188 from the alphaA-crystallin promoter.

Authors:  Catrin S Rutland; Christopher A Mitchell; Muneeb Nasir; Moritz A Konerding; Hannes C A Drexler
Journal:  Mol Vis       Date:  2007-01-19       Impact factor: 2.367

10.  Norrin attenuates protease-mediated death of transformed retinal ganglion cells.

Authors:  Song Lin; Mei Cheng; Wendelin Dailey; Kimberly Drenser; Shravan Chintala
Journal:  Mol Vis       Date:  2009-01-12       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.